MINNEAPOLIS – (July 19, 2023) – Allison Hubel, PhD will be celebrated as the incoming President of the Society for Cryobiology at its annual meeting in Minneapolis July 24 – 27, 2023.
Evia Bio is hosting a celebratory event at Target Field Tuesday, July 25th during the Twins vs. Mariners Major League Baseball game. Twin Cities life science leaders will join cryobiologists from around the world in honor of Dr. Hubel.
Dr. Hubel is a leading cryobiologist and Professor at the University of Minnesota, which is the host location for the event. She is also Founder and Chief Scientific Officer at Evia Bio.
The Society of Cryobiology’s annual event named CRYO2023 will bring together hundreds of the world’s top cryobiologists who are tackling critical challenges associated with biologics supply chains.
“I am incredibly honored to host this event in Minneapolis and to be named President,” said Dr. Hubel. “The biologics supply chain has always been challenging. I’m delighted to lead a society paving the way for more effective therapeutics.”
Cryopreservation is a critical component of successful cell therapies. Evia Bio delivers better and safer therapeutics through all-natural cryopreservation. Evia’s DMSO-free solutions improve post-thaw performance while simplifying manufacturing and reducing patient risk.
This event is also supported by:
Bullpen gathers life science executives and investors with the shared goal of helping each other. No sales pitches. No NDAs. No hidden agendas. Just good people.
CSC Leasing provides non-dilutive, low cost equipment financing solutions for growth-oriented life science companies.
Fredrikson an international law firm providing exceptional value to life science industry leaders.
Clinically Media is an award-winning marketing and creative firm serving the life sciences.
To request a ticket to the event, contact Evia Bio’s Director of Business Development Rachel Leon: [email protected].
More about Allison Hubel, PhD:
Allison Hubel, PhD combines her interest in heat and mass transfer, material science and biology to address issues related to preservation of cells and tissues for therapeutic applications. She uses imaging techniques to detect cell response to freezing, optimization algorithms to improve preservation outcome and a variety of other tools to understand the behavior of water during freezing and molecular mechanisms of protection.
Allison received her Ph.D. in Mechanical Engineering from the Massachusetts Institute of Technology. In addition to her role at Evia Bio she is a Professor, Mechanical Engineering Department at the University of Minnesota and University of Minnesota Medical School. She is also the Director of the BioCoR (Biopreservation Core Resource) and of the Technological Leadership Institute at the University of Minnesota.
More about Evia Bio:
Evia Bio delivers better and safer therapeutics through all-natural cryopreservation. Evia’s DMSO-free solutions improve post-thaw performance while simplifying manufacturing and reducing patient risk.
The company closed its seed round in Q2 2023 and is actively partnering with cell therapy developers, manufacturers and tools companies to validate the superiority of its products. The company will release its first product in Q4 2023, a DMSO-free solution for T Cells.
